Transitioning Patients with SMA from Paediatric to Adult Care
SMA HCP education | 10 Sep 2020 | Speaker: Professor Michelle Farrar | Australia
Associate Professor Michelle Farrar speaks about how adult SMA patient care is critical to enable optimal SMA management across the spectrum of the disease and what a successful transition from paediatric to adult SMA patients looks like.
Transitioning Patients with SMA from Paediatric to Adult Care
https://smadisease.global/https://www.smadisease.in/home/videos/transitioning-patients-with-sma-from-paediatric-to-adult-care.html
Related Videos
Speakers: Professor Ulrike Schara and Professor Tim Hagenacker
Neuromuscular SMA pediatric and adult experts from Essen, Germany discuss how the transition of SMA patients is managed from pediatric to adult SMA care settings.
Speakers: Dr. Ricardo Masson
Dr. Masson, Neuromuscular expert from Italy, shares how expectations and clinical
course of SMA in pediatric patients is changing with the availability of the DMTs
(disease modifying therapies).
Speakers: Dr. Ricardo Masson
Dr. Masson, Neuromuscular expert from Italy, shares his perspectives on frequently
asked questions from healthcare practitioners (HCPs) from around the world.
Speaker: Professor Michelle Farrar
Associate Professor Michelle Farrar discusses the merits of New born screening for initiating early treatment in SMA
Speaker: Professor Michelle Farrar
Associate Professor Michelle Farrar discusses the SMA phenotypes that are emerging from disease modifying therapies (DMTs) in SMA
Speaker: Dr. Ricardo Masson
Dr. Masson, Neuromuscular expert from Italy, stresses the importance of accurate early diagnosis of SMA
Speaker: Dr. Anna Mayhew
Dr. Anna Mayhew explains the importance of measuring patient-centred outcomes in SMA and aspects to consider when choosing scales to assess patients
Speaker: Dr. Anna Mayhew
Dr. Anna Mayhew presents the most commonly used motor performance scales suitable for Type II and Type III Spinal Muscular Atrophy.
Speaker: Dr. Anna Mayhew
Dr. Anna Mayhew presents the most commonly used scales for outcome measures in Type I Spinal Muscular Atrophy.
Speaker: Professor Nicolas Deconinck
In this video Prof. Deconinck gives an overview what to consider in interpretation and assessment of clinical trials in SMA.
Speaker: Professor Wolfgang Müller-Felber
Professor Müller-Felber discusses the chances of optimal development that newborn screening offers for SMA patients.
Speaker: Professor Eugenio Mercuri
In this video Prof Mercuri introduces his team and the topics that will be covered by this SMA Disease Management Experience series.
Speaker: Professor Eugenio Mercuri
In this video Prof Mercuri explains how the management and treatment of SMA is evolving in walkers patients, underlining the importance of a multidisciplinary approach and adherence to standards of care.
Speaker: Professor Eugenio Mercuri
In this video Prof Mercuri explains how the management and treatment of SMA is evolving in non-sitters patients, underlining the importance of a multidisciplinary approach and adherence to standards of care.
Speaker: Professor Eugenio Mercuri
In this video Prof Mercuri explains how the management and treatment of SMA is evolving in sitters patients, underlining the importance of a multidisciplinary approach and adherence to standards of care.
Speaker: Dottssa Giorgia Coratti
In this video Dottssa Coratti explains how the evolving therapeutic landscape in SMA is impacting the course of the disease and the model of care for patients.
Speaker: Dottssa Maria Carmela Pera
In this video Dottssa Pera gives an overview of clinical trials in SMA.